News
Zepbound Outcompetes Wegovy for Weight Loss in Head-to-Head Trials
Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the safety and efficacy of the injectable drugs. Learn more about the results of the SURMOUNT-5 Phase 3b trial.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...
Participants achieved an average weight loss of 20.2% with Zepbound ... However, the study was not powered to compare the safety and tolerability of Zepbound and the safety and tolerability ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback